There are 2789 resources available
749P - Cardiotoxicity in patients treated with PARP-inhibitors
Presenter: Mariola Blanco Clemente
Session: ePoster Display
750P - Safety and efficacy of platinum desensitization treatment in patients with ovarian cancer and platinum hypersensitivity
Presenter: Simona Manacorda
Session: ePoster Display
751P - Survival prognostic and surrogate values of the early modeled CA-125 KELIM in newly diagnosed advanced ovarian cancer: Data from the GCIG meta-analysis group
Presenter: Pauline Corbaux
Session: ePoster Display
752P - PARP-inhibitors beyond progression: A new way to manage oligometastatic ovarian cancer recurrence
Presenter: Eleonora Palluzzi
Session: ePoster Display
753P - Adverse events experienced by patients in the placebo arm of maintenance therapy trials in advanced ovarian cancer
Presenter: Sandy Simon
Session: ePoster Display
754P - Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer in Japan - GOTIC-019: A multi-institutional retrospective cohort study
Presenter: Shoji Nagao
Session: ePoster Display
786P - The impact of urine bladder catheterization after radical hysterectomy: Understanding patients’ experience
Presenter: Nicoline Schuur
Session: ePoster Display
787P - Endotoxicosis and properties of erythrocyte membranes in patients with cervical cancer receiving combination therapy with dendritic cell-based immunotherapy
Presenter: Irina Goroshinskaya
Session: ePoster Display
788P - Circulating human papillomavirus DNA as a biomarker of response in advanced cervical cancer
Presenter: Michelle McMullen
Session: ePoster Display
789P - PD-L1 and tumor mutational burden (TMB) in standard-of-care (SOC): Treated advanced cervical cancer
Presenter: Min-Hyun Baek
Session: ePoster Display